Steven Kelly - President, Chief Executive Officer, and Director

Angelo De Caro - Director. Angelo De Caro has served as Chairman and CEO of Patriot National Bancorp, Inc. since 2001 and as a Director of the company since 1999. His experience in finance and operations spans more than four decades, including 16 years from 1979-1996 with Goldman Sachs & Co., where he was a General Partner and Senior Financial Officer. There he oversaw operations departments including finance and taxation, as well as audit and risk management functions. In addition, he was a member of the Executive Committee of the company’s Swiss Private Bank. From 1966-1979, Mr. De Caro served as Vice President and Senior Financial Officer at Loeb Rhoades, Inc., an investment banking firm. He was educated at Long Island University and holds an M.S. in accounting and taxation, and a B.S. in accounting.

Philip Frost, M.D., PH.D. - Director. Dr. Frost holds the positions of Adjunct Professor of Cell Biology and Adjunct Professor of Medicine at The University of Texas M. D. Anderson Cancer Center. He has more than 30 years of experience in the fields of cell biology and oncology pharmaceutical research and development. From 2005 to 2007, Dr. Frost served as Executive Vice President and Chief Scientific Officer at ImClone Systems where he oversaw the company¹s research, clinical and regulatory departments. Prior to ImClone Systems, Dr. Frost served as Vice President of Oncology Co-Director of the Oncology Therapeutic Area Leadership Team at Wyeth where he was responsible for the development of various oncology compounds and contributed to the approval and commercialization of Mylotarg® for the treatment of a specific form of acute myeloid leukemia. Prior to joining Wyeth, Dr. Frost was a consultant for CaP Cure, and before that he served as Vice President for Oncology at the Sandoz Research Institute. Dr. Frost was an editor of Cancer Metastasis Reviews for 9 years, and he has published more than 100 research papers.

Dr. Frost received a Ph.D. in immunology from the Medical Research Council, Clinical Research Center, in London, an M.D. at the State University of New York at Buffalo, and a B.A. at Yeshiva University.

Neil Herskowitz - Director. Mr. Herskowitz joined our board of directors in May, 2006. He is a Managing Member of ReGen Partners LLC, a New York investment fund, as well as President of its affiliate, Riverside Claims LLC. He serves as a member of the board of directors for Manhattan Pharmaceuticals, Inc. and Chelsea Therapeutics Inc., both publicly traded specialty pharmaceutical development companies. He also serves on the board of directors of Starting Point Services for Children, a not-for-profit corporation. Mr. Herskowitz holds a B.B.A. in Finance from Bernard M. Baruch College.

J. Jay Lobell - Director. Mr. Lobell joined our board of directors in July, 2006. He serves as President and COO of Paramount BioSciences, LLC and Paramount BioCapital Asset Management, Inc. He also serves as CEO, Secretary and a member of the Board of Directors of Paramount Acquisition Corp. Mr. Lobell serves on the Board of Directors of NovaDel Pharma Inc. and is on the boards of several private biotechnology companies. Previously, Mr. Lobell was a partner at Covington & Burling, a law firm, where he provided litigation, regulatory and business advice. Mr. Lobell received his BA from Queens College and his JD from Yale Law School.

Antony Pfaffle, M.D. - Director. Dr. Pfaffle joined our board of directors in July, 2006. He serves as a healthcare consultant for Goldman Sachs & Company. He also recently joined Paramount Biosciences, where he evaluates drugs and devices for their venture capital team. He previously served as a consultant in medicine/nephrology at the Memorial Sloan-Kettering Cancer Center in New York. In addition, he founded Black Diamond Research (now BDR Research), and Trinity Advisory Group. Dr. Pfaffle received his BS/MD degree at The City College of CUNY and was later appointed to the faculty at both Weill-Cornell Medical College and the NYU School of Medicine.